These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26971793)

  • 1. Inhibition of Autophagy by Chloroquine Enhances the Antitumor Efficacy of Sorafenib in Glioblastoma.
    Liu X; Sun K; Wang H; Dai Y
    Cell Mol Neurobiol; 2016 Oct; 36(7):1197-208. PubMed ID: 26971793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorafenib exerts anti-glioma activity in vitro and in vivo.
    Siegelin MD; Raskett CM; Gilbert CA; Ross AH; Altieri DC
    Neurosci Lett; 2010 Jul; 478(3):165-70. PubMed ID: 20470863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sorafenib selectively depletes human glioblastoma tumor-initiating cells from primary cultures.
    Carra E; Barbieri F; Marubbi D; Pattarozzi A; Favoni RE; Florio T; Daga A
    Cell Cycle; 2013 Feb; 12(3):491-500. PubMed ID: 23324350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.
    Riedel M; Struve N; Müller-Goebel J; Köcher S; Petersen C; Dikomey E; Rothkamm K; Kriegs M
    Oncotarget; 2016 Sep; 7(38):61988-61995. PubMed ID: 27542273
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells.
    Ding X; Chaiteerakij R; Moser CD; Shaleh H; Boakye J; Chen G; Ndzengue A; Li Y; Zhou Y; Huang S; Sinicrope FA; Zou X; Thomas MB; Smith CD; Roberts LR
    Oncotarget; 2016 Apr; 7(15):20080-92. PubMed ID: 26956050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma.
    Shimizu S; Takehara T; Hikita H; Kodama T; Tsunematsu H; Miyagi T; Hosui A; Ishida H; Tatsumi T; Kanto T; Hiramatsu N; Fujita N; Yoshimori T; Hayashi N
    Int J Cancer; 2012 Aug; 131(3):548-57. PubMed ID: 21858812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of autophagic flux differently modulates cannabidiol-induced death in 2D and 3D glioblastoma cell cultures.
    Ivanov VN; Grabham PW; Wu CC; Hei TK
    Sci Rep; 2020 Feb; 10(1):2687. PubMed ID: 32060308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib induces growth arrest and apoptosis of human glioblastoma cells through the dephosphorylation of signal transducers and activators of transcription 3.
    Yang F; Brown C; Buettner R; Hedvat M; Starr R; Scuto A; Schroeder A; Jensen M; Jove R
    Mol Cancer Ther; 2010 Apr; 9(4):953-62. PubMed ID: 20371721
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of autophagy enhances the targeted therapeutic effect of sorafenib in thyroid cancer.
    Yi H; Ye T; Ge M; Yang M; Zhang L; Jin S; Ye X; Long B; Li L
    Oncol Rep; 2018 Feb; 39(2):711-720. PubMed ID: 29207150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-21 mediates sorafenib resistance of hepatocellular carcinoma cells by inhibiting autophagy via the PTEN/Akt pathway.
    He C; Dong X; Zhai B; Jiang X; Dong D; Li B; Jiang H; Xu S; Sun X
    Oncotarget; 2015 Oct; 6(30):28867-81. PubMed ID: 26311740
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TBK1 Inhibitor Exerts Antiproliferative Effect on Glioblastoma Multiforme Cells.
    Scuderi SA; Lanza M; Casili G; Esposito F; Colarossi C; Giuffrida D; Irene P; Cuzzocrea S; Esposito E; Campolo M
    Oncol Res; 2021 Sep; 28(7):779-790. PubMed ID: 33741083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cucurbitacin I induces protective autophagy in glioblastoma in vitro and in vivo.
    Yuan G; Yan SF; Xue H; Zhang P; Sun JT; Li G
    J Biol Chem; 2014 Apr; 289(15):10607-10619. PubMed ID: 24599950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
    Liu CY; Tseng LM; Su JC; Chang KC; Chu PY; Tai WT; Shiau CW; Chen KF
    Breast Cancer Res; 2013; 15(4):R63. PubMed ID: 23938089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single Agent and Synergistic Activity of the "First-in-Class" Dual PI3K/BRD4 Inhibitor SF1126 with Sorafenib in Hepatocellular Carcinoma.
    Singh AR; Joshi S; Burgoyne AM; Sicklick JK; Ikeda S; Kono Y; Garlich JR; Morales GA; Durden DL
    Mol Cancer Ther; 2016 Nov; 15(11):2553-2562. PubMed ID: 27496136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin and sorafenib as a novel and effective couple in programmed cell death induction in human gliomas.
    Jakubowicz-Gil J; Langner E; Bądziul D; Wertel I; Rzeski W
    Neurotox Res; 2014 Jul; 26(1):64-77. PubMed ID: 24366851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic interaction between the HDAC inhibitor, MPT0E028, and sorafenib in liver cancer cells in vitro and in vivo.
    Chen CH; Chen MC; Wang JC; Tsai AC; Chen CS; Liou JP; Pan SL; Teng CM
    Clin Cancer Res; 2014 Mar; 20(5):1274-1287. PubMed ID: 24520095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.
    Hamed HA; Tavallai S; Grant S; Poklepovic A; Dent P
    J Cell Physiol; 2015 Jan; 230(1):131-9. PubMed ID: 24911215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin K1 enhances sorafenib-induced growth inhibition and apoptosis of human malignant glioma cells by blocking the Raf/MEK/ERK pathway.
    Du W; Zhou JR; Wang DL; Gong K; Zhang QJ
    World J Surg Oncol; 2012 Apr; 10():60. PubMed ID: 22520038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of autophagy enhances apoptosis induced by proteasome inhibitor bortezomib in human glioblastoma U87 and U251 cells.
    Zhang X; Li W; Wang C; Leng X; Lian S; Feng J; Li J; Wang H
    Mol Cell Biochem; 2014 Jan; 385(1-2):265-75. PubMed ID: 24104452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin synergistically sensitizes FLT3-ITD-positive acute myeloid leukemia to sorafenib by promoting mTOR-mediated apoptosis and autophagy.
    Wang F; Liu Z; Zeng J; Zhu H; Li J; Cheng X; Jiang T; Zhang L; Zhang C; Chen T; Liu T; Jia Y
    Leuk Res; 2015 Dec; 39(12):1421-7. PubMed ID: 26505133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.